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摘要
目的:阐述慢性流泪与睑板腺炎的关系,探讨治疗睑板腺
炎对改善慢性流泪症状的疗效。
方法:对美国 OHSU 的 Casey 眼科研究所 2000/2009 年间
1000 例流泪患者进行回顾性研究。 其中 206 (20. 6%)例
患者通过裂隙灯检查被诊断为睑板腺炎,诊断标准包括:
睑板腺功能障碍,睑缘炎,睑缘毛细血管扩张,浅层点状角
膜病变。 治疗包括保持眼睑清洁,使用人工泪液,睑缘按
摩和热敷,全身口服抗生素和眼部抗生素点眼,皮质类固
醇点眼,饮食中补充 Omega-3 等治疗。
结果:所有患者中,206 例(20. 6%)患者被诊断为睑板腺
炎(平均年龄65.8 岁,平均流泪时间是2.78a)。 其中196 例
(95%)是白人;女性 106 例(51. 5%),男性 100 例(48. 5%)。
平均随访 5. 07mo。 通过治疗睑板腺炎,症状得到改善
152 例(73. 79%)。 症状未改善 43 例(20. 87%)。 在 43 例
患者中 14 例(6.81%)患者未找到治疗失败的原因,29 例
(14郾 08%)患者不愿做长期治疗而导致治疗失败。 失去
随访 11 例(5. 34%)。
结论:Casey 眼科研究所流泪患者中 20. 6% 患有睑板腺
炎,通过治疗 73. 78% 患者流泪症状改善。 我们认为:流
泪患者需注意其睑板腺情况,一旦诊断为睑板腺炎则应积
极治疗;其次通过各种手术治疗仍然流泪的患者,眼科医
生需注意其睑板腺的情况。
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Abstract
誗AIM: To investigate the relationship between chronic
epiphora and meibomianitis, and to explore the efficacy
of the meibomianitis treatment to improve chronic
tearing.
誗 METHODS: One thousand chronic epiphora patients
chart review in Casey eye institute during 2000 - 2009.
Review of 206 (20. 6%) chronic epiphora patients who
underwent slit lamp examination were diagnosed
meibomianitis. Diagnostic criteria were meibomian gland
dysfunction, blepharitis, lid margin telangiectasia and
hyperaemia punctuate superficial keratopathy. Treatment
included maintenance of lid hygene, use of artificial tears,
systemic and topical antibiotics, warm and moist
compresses, topical corticosteroid and diet
supplementation with Omega-3 fatty acids.
誗 RESULTS: Among all the patients, 206 ( 20. 6%)
meibomianitis patients (average age 65. 8 years, average
tearing time 2. 78 years). White patients 196 (95%);
female 106 (51. 5%), male 100 (48. 5%). Average follow
up time was 5. 07mo. 152 (73. 79%) of 206 meibomianitis
patients with tearing got improved through treatments. 43
(20. 87%) patients were treated without improvement.
The failure reasons cannot be found in 14 (6. 81%) of 43
patients. 29 ( 14. 08%) of 43 pateients with chronic
epiphora do not want to treat for a long time, which cause
the treatment failure. 11 (5. 34%) of 206 meibomianitis
patients lost to follow up.
誗CONCLUSION: The patients who presented to our office
for the tearing 20. 6% had meibomianitis. Through
treatment of meibomianitis, tearing improved 73.78%. So
patients with meibomianitis should treat it actively. Some
tearing patients after the surgery still tearing should pay
attention to treat meibomianitis.
誗 KEYWORDS: ocular surface; epiphora; tearing;
meibomianitis; blepharitis
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INTRODUCTION
T
here is little published information on the relationship
between chronic epiphora and meibomianitis. The cause
that leads to epiphora is complex and dependent on many
factors
[1]. Some epiphora can be the result of mechanical
failings in the lacrimal for the drainage system. Common
causes for epiphora are those of punctual stenosis and lacrimal
duct obstruction, ectropion and entropion. Epiphora also due
to reflex tearing, for instance, the emotions can make cry.
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a “pseudo plug冶 because of delayed tear clearance. Also,
epiphora may commonly be a manifestation of an ocular
surface disorder such as ocular allergy or ocular rosacea
[2-4].
Although there are different reasons to cause epiphora, the
symptom is the same. We reported the relationship between
chronic epiphora and meibomianitis. The meibomianitis
treatment is very important, which is able to improve chronic
tearing.
SUBJECTS AND METHODS
One thousand chronic epiphora patients reviewed in Casey eye
institute during 2000 - 2009. Among all the patients, 206
(20.6%) patients who underwent slit lamp examination were
diagnosed meibomianitis. Diagnostic criteria were meibomian
gland dysfunction, blepharitis, lid margin telangiectasia and
hyperaemia punctuate superficial keratopathy. Treatment
includes maintenance of lid hygene, use of artificial tears,
systemic and topical antibiotics, warm and moist compresses,
topical corticosteroid and diet supplementation with Omega-3
fatty acids.
RESULTS
Twenty point six percent of all the patients who presented to
our office for tearing had been diagnosed with the
meibomianitis. During the follow up time (5. 07 months on
average), 152 (73.78%) of 206 meibomianitis patients with
tearing got improved through treatments. Forty-three patients
(20. 87%) were treated without improvement. The failure
reasons cannot be found in 14 (6. 81%) of 43 patients, 29
(14.08%) of 43 pateients with chronic epiphora do not want
to treat for a long time, which cause the treatment failure.
Eleven (5.34%) of 206 meibomianitis patients lost to follow
up.
DISCUSSION
A review of the anatomy and physiology of tear production
highlights some of the difficulties and complexities in treating
these conditions. The principle structure of tear producing and
drainage system of the eye is the lacrimal apparatus which
comprises the lacrimal gland, lacrimal puncta, lacrimal
canaliculi, lacrimal canal, lacrimal sac and naso - lacrimal
duct. There is a mechanical process which moves the tears
across the surface of the eye and into the lacrimal apparatus.
The movement of tears is achieved by the process of
‘blinking爷 which produces a positive pressure under the eye
lids in the palpebral space. Thus when the eye lids are
closed, tears are forced towards the two drainage channels
known as the upper and lower lacrimal canaliculi. A slight
negative pressure is created in the lacrimal canal when the eye
lid is opened which draws the tears and any debris into the
lacrimal sac. In effect, there is a constant ‘ push爷 and
‘pull爷 on the flow of tears with each ‘blink爷
[5]. This is the
‘lacrimal pump爷. The drainage channels require the upper
and lower lacrimal canaliculi to be in contact with the surface
of the eye. For example, occasionally epiphora can be the
result of mechanical failings in the lacrimal drainage system.
The punctum is too small to adequately drain the tears from
the eye, mucin filaments obstruct the canaliculi and/ or
punctal stenosis or a blocked lacrimal duct. A simple dilation
and irrigation with saline will alleviate the symptoms. More
complex surgery is required either to make the punctual
opening wider or to refashion the lacrimal duct.
Conjunctivochalasis is due to a “ pseudo冶 blockage of the
puncta from the overhanging conjunctiva lead to the
appearance delayed tear clearance
[6]. Removal of the excess
conjunctiva may allow for better drainage and alleviation of the
epiphora. In addition, the lid margins also need to be in
contact with the surface of the eye and be able to meet
together when the eye is closed. It also assists in moving
debris across the eye either to form tears and be ‘cried爷 out
or swept into the lacrimal drainage system and discharged into
the nasal passages, ectropion can fail to move tearing to the
lacrimal drainage system. The loose skin of the lower lid can
be excised will alleviate the symptoms. The tear film
comprises three layers produced by the glands in the eyelids,
conjunctiva and cornea
[7]. The function of each layer is
integral to the proper functioning of the tear film as a whole.
To this three layers, lipids from the meibomian and Zeis
glands in the eyelids and mucin from goblet cells in the cornea
and epithelial cells in the conjunctival epithelium, the
aqueous layer produced by the lacrimal gland. Essentially the
mucin layer aids in keeping the tear film in place rather like a
‘bio - glue爷. The water layer allows the eye to remain
‘ moist 爷 and helps the cornea maintain good refractive
function. The lipid layer prevents the water layer from
evaporating. The presence of lysozyme and lactoferrin help
inhibit the growth of bacteria. Blepharitis, an inflammatory
condition of the eyelids associated with symptoms including
burning, irritation of the eyelid crusting, injection of the
eyelid margin and conjunctiva, is one of the most common
diseases routinely seen by ophthalmologists
[8-10]. With up to
20% of adults over the age of 45 reporting some discomfort,
the exact cause of blepharitis is unknown
[11]. Blepharitis
remains difficult to diagnose and treat. Although an
underlying inflammatory response is evident, it is thought that
changes in tear physiology, stability, and the ocular surface
also play a role. Blepharitis may be divided into anterior and
posterior forms. Anterior blepharitis around the
mucocutaneous junction is characterized by eyelids crusting,
styes, and collarettes at the base of the lashes. It may be
associated with staphylococcal infection, seborrhoea infection,
or a mixture of both. Posterior blepharitis is most commonly
linked with various disorders of the meibomian gland and is
caused by inflammation of the meibomian glands due to ductal
hyper keratinization or inspissations of secretion. Extensive
work by Mathers et al
[12] has shown this theory in humans.
The most common changes associated with posterior blepharitis
are those associated with the meibomian glands. Along the
margin of the lids there are a series of small sebaceous glands
called the meibomian glands
[13]. Meibomian gland secretions
help keep the eye moist and protect the tear film from
evaporation. This dysfunction of the meibomian glands is the
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The symptoms are insidious in onset, as with anterior
blepharitis, with patients often complaining of sore red eyes.
However, these symptoms generally vary throughout the day
with patients feeling that symptoms are worse in the morning
due to inflammatory mediators attacking the anterior surface
during sleep. Studies on both rabbits and humans have
attempted to show correlation between meibomian gland
dysfunction and evaporative dry eye, including hyperaemia
and talengiectasia, ultimately leading to fibrosis of the
meibomian gland. Earlier work on rabbits reported that
cauterization of the meibomian gland orifices stopped meibum
delivery to the ocular surface. This showed a rapid increase in
the evaporation of the tear film, indicating that meibomian
glands are vital in the production of the outer tear film lipid
layer. They reported that the loss of meibomian glands
increases tear evaporation rate as well as decreasing tear
production and increasing tear osmolarity
[14]. If these fail to
produce sufficient lipids or these lipids cannot reach the
surface of the eye, the oils that are produced become thicker
(looking like toothpaste). Although there are many reasons
why the glands can become clogged, one common cause may
be hormonal changes in estrogen levels, can cause a
thickening of the oils. The changes of estrogen levels also
cause a proliferation of staphylococcal bacteria that normally
thrive on the ocular surface
[15]. These bacteria invade the
meibomian glands and colonize there. In this condition small
concretions collect around the base of the eyelashes and can
cause irritation leading to a low level inflammation
[16]. This
can also lead to the meibomian glands becoming blocked
producing a chalazion or lump on the eye lid or if it is a
superficial gland (Zeis) then a sty will form. Both of these
conditions will further reduce the efficient working of the tear
film by distorting the anatomy of the eye. The double trouble
caused by the thickening of the oils plus the bacteria gradually
decreases the secretion of oils from the glands. Long term
chronic inflammation of the eye lids can cause meibomianitis,
a deterioration of the tear film, dysfunction and inflammation
of these glands. Meibomianitis can be diagnosed during your
regular eye examination, so there are no special tests
required, depending on the severity of the condition
[17,18].
The result of meibomian gland dysfunction, the tears will
evaporate before they have cleaned the eye effectively which
will cause the lacrimal gland to produce more aqueous tears.
Treatment usually consists of both topical and oral antibiotics
(usually tetracycline, doxycycline or erythromycin) to help
break down the thickened lipid secretions
[19]. Moreover, in
order to help restore the function of the meibomian gland, the
oily secretions should always be keept from solidifying. Warm
and moist compresses used 2 -3 times a day help melt the
lipid “ plug 冶 and allow the antibiotics to penetrate the
meibomian glands. Another technique in the treatment of
meibomianitis is the daily use of special eyelid scrubs to
reduce debris on the lids and help unclog pores. Dietary helps
with the meibomianitis treatment
[20,21]. Current research about
diet supplementation with Omega-3 fatty acids indicates that
they can stabilize inflammation and help restore normal oils.
Omega-3 fatty acids are essential fatty acids that body can蒺t
produce – body must obtain them from diet. The two best
sources for omega-3 fatty acids are fish oil and flaxseed oil.
Studies have shown that people with meibomianitis, when
given Omega-3 supplements, experience an improvement in
the oil layer covering their tear films. In our case, 206
meibomianitis patients with chronic epiphora who treated the
meibomianitis got improved 73. 78%. Eighteen (8. 74%)
among 206 meibomianitis patients with chronic epiphora on
presentation to Casey eye institute, the patient underwent
treatment of chronic epiphora with surgery before their
meibomianitis was thoroughly addressed. They underwent
lacrimal dilation and irrigation and they underwent different
surgery, including bilateral dacryocystorhinostomy with
subsequent John tube placement, removal of the excess
conjunctiva, punctoplasty allow for better drainage and
alleviation of the epiphora. The tearing was unchanged several
months after surgery. Casey eye institute examination had
significant papillary reaction with diffuse telengiectatic vessels
along the eyelid margins. A diagnosis of meibomianitis was
made. Through treatment, several weeks later, their
symptoms were improved. Surgery and meibomianitis were
treated at the same time, no improved were 43 (20. 89%) of
206 patients with chronic epiphora. The failure reasons cannot
be found in 14 (6.81%) of 43 patients. Indeed the management
is complicated due to a number of factors, 29 (14.08%) of 43
pateients with chronic epiphora do not want to treat for a long
time, which cause the treatment failure. 11 (5. 34%) of 206
patients lost to follow up.
Meibomianitis is a complex interaction of various factors
[22],
including abnormal lid margin secretions, microbial
organisms, and abnormalities of the tear film. The main
treatment is an eyelid hygiene, which need to be continued
long time, some patients cannot take a long time to treat their
eyelid, so always cause the treatment failure. Topical
antibiotics are used to reduce the bacterial load. Topical
corticosteroid preparations may be helpful in patients with the
inflammation. Some meibomianitis can present with a range of
signs and symptoms, and its management can be
complicationed by a number of factors. Our recommendations
of careful lid hygiene possibly combined with the use of topical
antibiotics, with or without topical steroids. Systemic
antibiotics may be appropriate in some patients.
In conclusion, it is important to consider a differential
diagnosis before pursuing invasive therapeutic options. If the
patient has the meibomianitis, we should treat it. Some
tearing patients after the surgery still tearing should pay
attention to treat the meibomianitis.
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